Related references
Note: Only part of the references are listed.Design and synthesis of novel halogen rich salicylanilides as potential antileishmanial agents
Jhajan Lal et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)
Discovery of rafoxanide as a novel agent for the treatment of non-small cell lung cancer
Ankang Hu et al.
SCIENTIFIC REPORTS (2023)
Rafoxanide sensitizes colorectal cancer cells to TRAIL-mediated apoptosis
Federica Laudisi et al.
BIOMEDICINE & PHARMACOTHERAPY (2022)
Drug screening approach against mycobacterial fatty acyl-AMP ligase FAAL32 renews the interest of the salicylanilide pharmacophore in the fight against tuberculosis
Nguyen-Hung Le et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2022)
Bio-evaluation of fluoro and trifluoromethyl-substituted salicylanilides against multidrug-resistant S. aureus
Jhajan Lal et al.
MEDICINAL CHEMISTRY RESEARCH (2021)
Sulfated polyborate-H2O assisted tunable activation of N-iodosuccinimide for expeditious mono and diiodination of arenes
Balu Misal et al.
TETRAHEDRON LETTERS (2021)
NCBSI/KI: A Reagent System for Iodination of Aromatics through In Situ Generation of I-Cl
Amey Palav et al.
JOURNAL OF ORGANIC CHEMISTRY (2021)
Salicylanilides Reduce SARS-CoV-2 Replication and Suppress Induction of Inflammatory Cytokines in a Rodent Model
Steven Blake et al.
ACS INFECTIOUS DISEASES (2021)
Antitumor effects of rafoxanide in diffuse large B cell lymphoma via the PTEN/PI3K/Akt and JNK/c-Jun pathways
Wan He et al.
LIFE SCIENCES (2020)
A convenient and efficient H2SO4-promoted regioselective monobromination of phenol derivatives using N-bromosuccinimide
Yong-Qi Wu et al.
SYNTHETIC COMMUNICATIONS (2020)
Repositioning rafoxanide to treat Gram-negative bacilli infections
Andrea Miro-Canturri et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
Structural development of N-(4-phenoxyphenyl)benzamide derivatives as novel SPAK inhibitors blocking WNK kinase signaling
Shinya Fujii et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
Rafoxanide promotes apoptosis and autophagy of gastric cancer cells by suppressing PI3K /Akt/mTOR pathway
Jia-Zhou Liu et al.
EXPERIMENTAL CELL RESEARCH (2019)
Iodination of industrially important aromatic compounds with aqueous potassium triiodide
V. Sharma et al.
RUSSIAN JOURNAL OF ORGANIC CHEMISTRY (2016)
Dual Protonophore-Chitinase Inhibitors Dramatically Affect O. volvulus Molting
Major Gooyit et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Selective Reduction of Halogenated Nitroarenes with Hydrazine Hydrate in the Presence of Pd/C
Fang Li et al.
SYNLETT (2014)
Efficient Construction of Pyrano[3,2-a]carbazoles: Application to a Biomimetic Total Synthesis of Cyclized Monoterpenoid Pyrano[3,2-a]carbazole Alkaloids
Ronny Hesse et al.
CHEMISTRY-A EUROPEAN JOURNAL (2013)
Synthesis of novel histamine H4 receptor antagonists
Charlotte A. L. Lane et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Antimycobacterial Activity of Salicylanilide Benzenesulfonates
Martin Kratky et al.
MOLECULES (2012)
Salicylanilide Ester Prodrugs as Potential Antimicrobial Agents - a Review
Martin Kratky et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
Synthesis, Characterization, X-Ray Structural Analysis, and Iodination Ability of Benzyl(triphenyl)phosphonium Dichloroiodate
Hossein Imanieh et al.
HELVETICA CHIMICA ACTA (2011)
Salicylanilide carbamates: Antitubercular agents active against multidrug-resistant Mycobacterium tuberculosis strains
Juana M. Ferriz et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Salicylanilide esters of N-protected amino acids as novel antimicrobial agents
Ales Imramovsky et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Salicylanilides: Selective inhibitors of interleukin-12p40 production
Michael E. Brown et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Design, synthesis, and Multivariate quantitative structure-activity relationship of Salicylanilides-Potent inhibitors of type III secretion in Yersinia
Markus K. Dahlgren et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Anthelmintic resistance: The state of play revisited
Abdul Jabbar et al.
LIFE SCIENCES (2006)
The oriented development of antituberculotics:: Salicylanilides
Karel Waisser et al.
ARCHIV DER PHARMAZIE (2006)
Small molecules with antimicrobial activity against E-coli and P-aeruginosa identified by high-throughput screening
R. De La Fuente et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Salicylanilides as inhibitors of the protein tyrosine kinase epidermal growth factor receptor
C Liechti et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2004)
Relationship between the structure and antimycobacterial activity of substituteds salicylanilides
K Waisser et al.
ARCHIV DER PHARMAZIE (2003)
On the relationship between the substitution pattern of thiobenzanilides and their antimycobacterial activity
J Kunes et al.
FARMACO (2002)
Share Paper
